Tolvaptan in Hyponatremic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Advanced Cancers
Related studies linked through entity extraction aliases.
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
- Status
- COMPLETED
- Phase
- PHASE1
Trientine and Carboplatin in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Lapatinib With Sirolimus or Metformin
- Status
- COMPLETED
- Phase
- PHASE1
HAI Abraxane With Gemcitabine and Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study
- Status
- COMPLETED
- Phase
- N/A
A First in Man Study of MABp1 in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Physician Perceptions About Parenteral Hydration in Latin America and Spain
- Status
- UNKNOWN
- Phase
- N/A
Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients
- Status
- WITHDRAWN
- Phase
- NA
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
TTP607 in Refractory Solid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing
- Status
- COMPLETED
- Phase
- N/A
Self Reported Deviations From Opioid Analgesic Prescription
- Status
- COMPLETED
- Phase
- N/A
An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status
- Status
- COMPLETED
- Phase
- PHASE1
LY2275796 in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib in Combination With Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
- Status
- UNKNOWN
- Phase
- N/A